Innovative Pharmaceutical Development from True South American Rainforest Plant

Who we are

Berry Pharmaceuticals, LLC is a Texas-based Life Science Company founded for the purpose of developing new pharmaceutical medicines derived from the natural botanical extracts of a very specific variety of true South American rainforest plant.

OUR MISSION

“Altruistically helping heal disease for improved quality of life through ethical innovative pharma development.

From Ancient Practice to Modern Medicine

Although this plant has been used for centuries by the native rainforest people to treat skin wounds and other conditions, this plant has never been researched for its pharmaceutical potential … until now.

How We began

We grew our very special plant in collaboration with Texas A&M

For over a decade, and in collaboration with Texas A&M University, Don Wayne Berry, M.D., retired Texas heart surgeon, has passionately researched, vetted, and cloned a potent variety of this very special plant.

Our discoveries were issued patents, protecting integrity

New potential dermatological drugs have been developed by Berry Pharmaceuticals, LLC. To date, the Company has been issued five disease-specific USTPO patents with a sixth patent pending.  Discovery and institutional research have verified the potential strength of the botanical extracts

New drugs now ready to begin clinical trial process as topical pharmaceuticals

  • New drugs will pass through FDA Botanical Guidance Pathway for pharmaceutical approval
  • All standards are GMP (good medical practice) level
  • The initial drugs the Company plans to submit to the FDA will each be represented in commercial markets
  • Each drug to be submitted directly meets current needs, specifically in the medical fields of dermatology, radiation oncology, and breast cancer management
  • Studies will begin when funding is secured.

If you find our story compelling, contact us to partner in furthering our mission to heal people’s diseases through innovative pharmaceutical development.

A full business plan and presentation are available for qualified investors.